ID   SDAR3
AC   CVCL_AV65
DR   Wikidata; Q54952713
RX   CelloPub=CLPUB00321;
WW   http://www.mayo.edu/research/documents/follicular-thyroid-carcinoma/doc-20088094
CC   Derived from site: Metastatic; Jugular vein; UBERON=UBERON_0004711.
ST   Source(s): CelloPub=CLPUB00321
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 27
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV63 ! SDAR1
OI   CVCL_AV64 ! SDAR2
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00321;
RA   Marlow L.A., Rohl S.D., Kennedy G.T., Milosevic D., Grebe S.K.G.,
RA   Reddi H.V., Eberhardt N.L., Morris J.C., Trujillo M.A., McDonough S.J.,
RA   McIver B., Bible K.C., Casler J.D., Smallridge R.C., Copland J.A. 3rd;
RT   "Newly characterized follicular thyroid carcinoma cell lines
RT   demonstrate antitumor synergy in response to combined MEK and AKT
RT   inhibitors.";
RL   (In conference) 82nd annual meeting of the American Thyroid Association; pp.A61-A61; American Thyroid Association; Quebec; Canada (2012).
//